month=01
year=2010
05 January 2010
|
For immediate release
|
5 January 2010
|

TYRATECH, INC.
(“TyraTech”
or “the Company”)
Board Changes
The Board of TyraTech, Inc.
(AIM: TYR) a leading independent novel eco-technology company for human, animal
and environmental health, announces that Dr Douglas Armstrong has stepped down
as Chief Executive Officer and has resigned as a director of the Company.
Alan Reade, currently a
Non-executive Director who has been on the Board of TyraTech since the
Company’s AIM flotation in 2007, has assumed the role of Executive
Chairman and will take charge of the day to day affairs of the Company.
Alan Reade’s career spans
over thirty years within the life sciences industry. From
2000 until his retirement in 2005, he served as executive chairman of Merial
Limited, a leading animal health company and joint venture between Merck &
Co. Inc. and Sanofi- Aventis. Earlier in his career he was head of global
integration at Aventis, where he was in charge of merger integration, and Chief
Executive Officer and member of the Global Management Board of Rhone-Poulenc Agrochimie.
Geoffrey Vernon, currently
Non-executive Chairman assumes the role of Non-Executive Director.
All
Officer and Board changes are with immediate effect.
Geoffrey
Vernon, Non-Executive Director commented:
“On behalf of the Board, I would like to
thank Doug for his contribution to the development of TyraTech since the
Company’s Admission to AIM in 2007 and we wish him every success in his future
endeavours. Similarly the Board would like to thank Alan for stepping into the
Executive Chairman’s position. Alan has a wealth of experience within the
industry particularly in animal health and through his more active executive role
will be invaluable to the continued smooth running of the business.”
- Ends -
For further information please
contact:
TyraTech Inc.
Geoffrey Vernon,
Non-Executive director +44
(0)20 7466 5000
www.tyratech.com
Nomura Code
Securities
Clare Terlouw / Chris
Golden +44
(0)20 7776 1200
www.nomuracode.com
Buchanan Communications
Lisa Baderoon/ Catherine Breen / Stasa Filiplic +44 (0)20 7466
5000
www.buchanan.uk.com